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Abstract Breast cancer is the most frequent neoplasia in women and is respon-
sible for approximately 13.8% of deaths per year for this gender. It has been sug-
gested that JAK2, STAT3, and NF-jB gene expression is involved in this type of
cancer. The objective of the present study was to determine the effect of bistriazole
in these signaling pathways in patients with breast cancer and benign mammary
lesions. The inhibitory concentration 50 of bistriazole was calculated in cell cultures
of patients with benign lesions, Probit = 4.6 lM with IC = 95%. The study was
performed by examining 63 women who submitted to mammary biopsies. Biopsies
of the mammary lesions were performed, gene expression was determined, and cells
were cultured in the presence of 4.6 lM bistriazole. We found that breast cancer is
related to age greater than 50 (P B 0.01), being overweight (P B 0.023) and having
a waist circumference larger than 80 cm (P B 0.01). The gene expression of JAK2,
STAT3, and NF-jB was higher in groups of patients with breast cancer, while
SOCS3 expression was lower. After being exposed to bistriazole, the expression of
JAK2 and STAT3 decreased, and the expression of SOCS3 and NF-jB increased. In
conclusion, this molecule in development has an effect on the gene expression of
JAK3 and STAT3; nevertheless, the lack of change in NF-jB indicates that it is not
a regulator of inflammation, and therefore, more studies should be performed.
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Introduction
Breast cancer has become an extremely important health issue in Mexico due to its
increasing incidence and mortality. In 2009, 4964 deaths were recorded, with a
mortality rate of 1.70 per 100,000 women above 25 years old, representing an
increase of 30% during the past 20 years (Cha´varri-Guerra et al. 2012). The factors
that are considered high-risk are age, family history, early menstruation, late
menopause, nulliparity, late age of the first pregnancy, obesity, a sedentary lifestyle,
the use of hormone replacement therapy, and carrying the BRCA1 and BRCA2
genes (Perks and Holly 2011; Murray and Davies 2013).
In accordance with international guidelines, the established therapy is determined
based on the status of HER2 and hormone receptors (PR and ER) and the onset of
menopause. The decision for administration of adjuvant chemotherapy is based on
age, nodal status, grade, and tumor size. Recently, gene expression profiles have
been considered as factors that have high prognostic and predictive values that may
be used to provide more personalized and effective therapies. Some examples of
gene expression profiles being examined are the signaling pathways of JAK2
(belonging to the Janus kinase that makes up the family of cytoplasmic receptors of
tyrosine kinases) (Yun et al. 2012; Gupta et al. 2012; Zou et al. 2011) and STAT3
(signal transducers and activators of transcription), kinases that are involved in the
differentiation and development of breast cancer and are often found over-expressed
in this disease (Jarde´ et al. 2011; Haricharan and Li 2014). One of the suppressors
and regulators of this pathway is Suppressor of cytokine signaling (SOCS3) (Babon
et al. 2012). This suppression can be deregulated or inhibited during carcinogenesis
as a result of phosphorylation of STAT3. By inhibiting phosphorylation, the
function of the cytokine suppressor is recovered. The activation of JAK2/STAT3
has been widely studied and is now considered a relevant therapeutic target in
different types of cancer (Shanmugam et al. 2011).
Among the factors that play a significant role in the development of breast
cancer, obesity is of primary interest as it is linked to an increase in angiogenesis
and alterations in the serum levels of powerful regulators of cell growth, such as
adiponectin, leptin, and estrogen (Jarde´ et al. 2011). Obesity and being overweight
are prevailing conditions world-wide. The World Health Organization (WHO)
reports that more than 400 million people are obese and predicts an increase to 700
million by 2015 (Guo et al. 2012; Ray and Cleary 2012).
Processes such as inflammation and the immune response are involved in the
development of breast cancer because they represent two of the most significant
mechanisms regulating progression of this cancer type that are regulated by nuclear
factor-kappa B (NF-jB). There are several stimuli that can activate the signaling
pathway of NF-jB; among them are the pro-inflammatory cytokines (TNF-a, IL-1,
IL-6), bacteria, virus, viral proteins, lipopolysaccharides, and physical and chemical
stress. Cellular stress that can activate NF-jB includes radiation, ionization,
chemotherapeutic agents, and reactive oxygen species (ROS) that cause oxidative
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stress and, as a result, DNA damage, which causes inflammation and the
transcription of genes such as cycloxigenase-2 (Cox-2), bcl-2, bcl-xl, XIAP,
survivin, VEGF, and AKT (Ling and Kumar 2012; Li et al. 2010; Moretti et al.
2012). Among the chemotherapeutic agents that activate NF-jB are taxol,
tamoxifen, paclitaxel, vinblastine, vincristine, doxorubicin, daunomycin, 5-flour-
ouracil, cisplatin, and bortezomib; therefore, this pathway is highly associated with
treatment resistance. The need for new and more effective treatments to reduce the
mortality rate caused by breast cancer is urgent.
Several triazoles and bistriazoles possess pharmacological activities, such as
antibacterial, anti-fungal, anti-inflammatory, and antitumoral (Duan et al. 2013),
with high stability under conditions of acid or basic hydrolysis and oxidation and
reduction due to their high aromatic stabilization. Their heterocycles possess large
dipole moments that are capable of binding to hydrogen, which favorably forms
bonds with biomolecules (Kumar et al. 2012; Hou et al. 2011). It has also been
observed that these molecules inhibit the polymerization of tubulin, which is
essential for cell division, and the aminopeptidase methionine enzymes (MetAPs)
that play an important role in eliminating methionine, an indicator of synthesis of
new polypeptide chains. In humans, some proteins with this inhibitory activity have
been described: METAP, MetAP1, and MetAP2, which play critical roles in the
proliferation and growth of cells of various types of tumors (Kumar et al. 2012).
The aim of this study was to evaluate the activity of the bistriazole 1,3-bis(4
phenyl)-1H-1,2,3-triazolyl-2-propanolol in cell cultures from mammary biopsies
through gene expression analysis of JAK2/STAT3, NF-jB, and SOCS3 in a cell
culture of biopsies from mammary lesions.
Materials and Methods
Study Design
This was a prospective cross-sectional study performed on patients from the
Maternal–Perinatal Hospital ‘‘Mo´nica Pretelini Sa´enz’’ (HMPMPS), Health Institute
of the State of Mexico (ISEM), Toluca, State of Mexico during the period of August
2013 to March 2014.
Patients
We evaluated women whose profiles showed a high probability of potential breast
cancer, excluding those with antineoplastic treatment and hormonal therapy.
Anthropometric Characteristics
Weight (kg), height (m), and waist circumference of all of the patients who
participated in the study were recorded. Women were classified according to their
body mass index (BMI) as normal weight (BMI\ 24.9 kg/m2), overweight
(24.9 kg/m2\BMI\ 29.9 kg/m2), or obese (BMI[ 30 kg/m2).
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Laboratory
Approximately, 10 mgof thebiopsywas cultivated (culturemediumRPMI1640,Sigma-
Aldrich,Germany) and exposed to 1,3-bis(4 phenyl)-1H-1,2,3-triazolyl-2-propanolol for
48 h at a concentration of 4.6 lM. Subsequently, RNA was extracted with the MagNA
Pure Lc RNA Isolation Kit III (Roche, Germany) in the MagnA Pure LC 2.0 (Roche,
Germany). The RNA was diluted to a concentration of 10 lg of cDNA (High Capacity
RNA-to-cDNA, Applied Biosystems). In the real-time polymerase chain reaction (RT-
qPCR), specific probes for STAT3 (Hs 01047580_m1), JAK2 (Hs 01078124_m1), NF-
jB (Hs 00765730_m1), SOCS3 (Hs 02330328_s1) were used, with 18 s
(Hs99999901_s1) as a control gene (TaqMan Gene Expression Assays-Inventoried,
AppliedBiosystems,UK). These valueswere quantified in the7500FastReal-TimePCR
System (Applied Biosystems, UK). All molecular studies were processed at the
Laboratory of Molecular Biology, Medical Sciences Research Center (CICMED),
Autonomous University of the State of Mexico (UAEMex), Toluca, Mexico.
Samples
Biopsies directed by ultrasound-guide (Voluson E8, GE Healthcare, USA) or
stereotaxy (MultiCare Platinum prone breast biopsy table, Hologic, Germany) selected
through the BI-RADS (Breast Imaging Reporting and Data System) scale (grade 4 a, b,
c), of suspicious lesions of malignancy. The sampling was directed by ultrasound-
guide specific to injury so that the amount of stromal tissues and inflammatory cells did
not interfere with the mammary cancer epithelia to measure RNA levels.
Inhibitory Concentration 50 (IC50)
Analysis was performed with the Probit model and, according to calculations for the
point of 50% of dead cells, the inhibitory concentration 50 (IC50) was found to be
4.6 lM, with a confidence interval (CI) of 95%. The results were analyzed with the
statistical program IBM SPSS, version 22.
Study Ethics
This study was approved by the Ethics Committee of the HMPMPS (2010-12-156),
and it was performed under the strictest ethical standards of the Declaration of
Helsinki, Fortaleza, Brazil. Informed consent was obtained from all study participants.
Statistical Analysis
A Student’s t test and the Mann–Whitney U test were performed to determine if
there were significant differences among the study groups; a multiple correlation
was established to determine the association between expression levels of JAK2/
STAT3, SOCS3, NF-jB, and their suppression with the bistriazole. The F-test was
used to evaluate differences of proportions among the study groups; for such
purposes, we used SPSS, version 22 software.




Sixty-three female breast biopsy samples were obtained, and two groups were formed
with these samples: the control groupwith benign lesions (n = 42) and the breast cancer
group with malignant lesions (n = 21). Table 1 shows anthropometric measurements
and the grade of gene expression of the biopsies before and after being exposed to
bistriazole and its statistical significance. Sampling was directed by ultrasound-guide
specific to injury so that the amount of stromal tissue and inflammatory cells did not
interfere with the mammary cancer epithelia to measure RNA levels.
Gene Expression
According to the statistical data, we observed that the gene expression of STAT3,
JAK2, and NF-kB was higher in the cancer group than in the control group; in the
case of SOCS3, the expression was lower in the cancer group.
The Pearson correlation was used to analyze gene expression of the biopsies
before being subjected to bistriazole treatment, and a moderately statistically
significant association between the expression of STAT3 and JAK2 (rP = 0.734,
Table 1 Anthropometric characteristics and gene expression of the population surveyed
Variable Control group n = 42
Average ± SD
Group with cancer n = 21
Average ± SD
P
BMI (kg/m2) 25.52 ± 3.96 27.58 ± 2.97 0.017
Age (years) 44.98 ± 15.3 53.24 ± 9.53 0.036
Weight (kg) 62.51 ± 11.5 67.93 ± 6.45 0.011
Height (m) 1.56 ± 0.68 1.56 ± 0.56 0.901
Waist circumference
(cm)
89.01 ± 11.71 94.54 ± 8.16 0.026
Hips circumference
(cm)
98.65 ± 11.11 105.54 ± 6.13 0.006
STAT3a 1.12 ± 1.0 8.39 ± 3.6 0.001
JAK2a 0.03 ± 0.02 2.02 ± 0.90 0.002
NF-jBa 0.94 ± 0.8 2.88 ± 1.4 0.001
SOCS3a 14.27 ± 11.2 5.08 ± 3.8 0.005
NF-jB with bis-
triazolea
28.68 ± 24 25.15 ± 15.1 0.78
SOCS3 with bis-
triazolea
344.7 ± 249 495 ± 151.9 0.24
BMI body mass index, JAK2 Janus kinase 2, STAT3 signal transducer and activator of transcription 3,
SOCS3 suppressor of cytokine signaling 3, NF-jB nuclear factor B
a 2DDCT relative expression using 18S housekeeping gene
Statistical test: Mann–Whitney U test and Wilcoxon signed-rank test
p Statistically significant (\0.05)
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p\ 0.05), STAT3 and NF-jB (rP = 0.547, p\ 0.05), and STAT3 and SOCS3
(rP = -0.336, p\ 0.05) was found, with the former being inversely proportional.
After biopsy exposure to bistriazole, it was observed that gene expression of
STAT3 and JAK2 was suppressed in both the control group and the cancer group. In
the case of SOCS3 and NF-kB, bistriazole increased gene expression levels.
The age and circumferences of waist and hips increased as the BMI did. An increase
in STAT3, JAK2, and NF-jB also related to increases in the BMI. On the contrary,
SOCS3 showed an inverse correlation to BMI. These results are shown in Table 2.
In the survey applied to the study subjects, the following information was asked:
family history of breast cancer, whether they breastfed their children, and if they
procreated or not. These data were analyzed with the Student’s t test, and the results
are shown in Table 3.
No differences between the two studied groups were found in relation to family
history of cancer, breastfeeding, and procreation.
Discussion
Over-expression of the JAK2/STAT3 signaling pathway has been proposed as a
therapeutic target in breast cancer due to its strong involvement in the proliferation
and development of this type of neoplasia (Furth 2014; Santilla´n-Benı´tez et al.
2012; Harbeck et al. 2010). Even more, SOCS3 is a cytokine that regulates this
signaling pathway (Babon et al. 2012; Linossi et al. 2013) and is able to suppress or
Table 2 Characteristics of the patients and their relation with the BMI
Normal weight n = 22
Average ± SD
Overweight n = 32
Average ± SD
Obesity n = 9
Average ± SD
p1 p2
Age (years) 44.18 ± 17.3 48.59 ± 13.18 53.33 ± 3.7 0.32 0.12








91.62 ± 9.27 105.1 ± 8.3 108.8 ± 10.9 0.001 0.001
STAT3a 3.07 ± 3.8 5.17 ± 4.7 5.65 ± 4.7 0.34 0.31
JAK2a 0.02 ± 0.01 0.9 ± 0.8 1.7 ± 2.3 0.12 0.16
NF-jBa 1.47 ± 1.2 2.30 ± 1.7 1.45 ± 1.0 0.38 0.71
SOCS3a 11.76 ± 11.8 10.46 ± 9.9 7.19 ± 6.17 0.98 0.56
BMI body mass index, JAK2 Janus kinase 2, STAT3 signal transducer and activator of transcription 3,
SOCS3 suppressor of cytokine signaling 3, NF-jB nuclear factor B
a 2DDCT relative expression using 18S housekeeping gene
Statistical test: Mann–Whitney U test and Wilcoxon signed-rank test
p Statistically significant (\0.05)
p1 Between normal weight and obesity
p2 Between overweight and obesity
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control the over-expression of STAT3. Thus, the function of this cytokine might
contribute to the inhibition of proliferation and development of breast cancer cells.
Recently, a Cu(I)-catalyzed synthesis pathway for cycloadditions of azide-alkyne
called ‘‘click’’ (CuAAC) was discovered; the bistriazoles can be synthesized more
quickly and with higher efficiency and better performance (Harbeck et al. 2010).
This reaction is the best route to obtain 1,2,3-triazoles, which have been found to
possess interesting biological properties that could be important for the design of
new drugs (Gonza´lez et al. 2011; Schweinfurth et al. 2011; Sztanke et al. 2008).
The IC50 from the compound that was evaluated in this study was 4.6 lM; this
value is below concentrations obtained by other authors who have worked with
triazolic compounds (Xia et al. 2012; Li et al. 2013).
In this study, it was found that 1,3-bis(4-phenyl)-1H-1,2,3-triazolyl-2-propanolol
is capable of suppressing the JAK2/STAT3 signaling pathway in cells from breast
cancer biopsies at a concentration of 4.6 lM. Additionally, the expression of
SOCS3 in these cells also increased as a result of treatment from 5.08 to 459 relative
units (RU); therefore, we expect that based on the anti-inflammatory properties of
this compound, it would suppress or reduce expression of NF-jB, which participates
in the neoplastic processes (Oeckinghaus et al. 2011). The results are shown in
Table 1.
A statistically significant association between the expression of JAK2 and
STAT3 was found because the former is activated by JAK2. A correlation between
STAT3 and NF-jB was also found, as both signaling pathways are activated by
interleukins, mainly IL-6 (German et al. 2011; Aizpurua et al. 2010), the pro-
inflammatory cytokine over-expressed in overweight and obese patients. Neverthe-
less, when the cells of a mammary lesion are treated with bistriazole and the
expression levels of JAK2 and STAT3 have been suppressed, NF-jB must be
activated by other pathways in addition to the JAK2/STAT3 pathway.
A relevant factor leading to breast cancer is obesity that affects the regulation of
serum levels of adiponectin, leptin, and estrogens (Jarde´ et al. 2011). It has been
shown that leptin activates the JAK2/STAT3 signaling pathway, contributing to the
Table 3 Family history, breastfeeding, and gravida in cases of breast cancer
Diagnosis Total P
Control n = 42 With cancer n = 21
Family history of cancer Yes 8 4 15 1.0
No 34 17 52
Breastfeeding Yes 27 17 44 0.12
No 12 4 16
A little 3 0 3
Gravida Had children 32 17 49 0.67
Didn´t have children 10 4 14
Statistical test: student’s t test
p Statistically significant (\0.05)
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development of breast cancer (Napoleone et al. 2012). One way to evaluate obesity
is through BMI measurements (Khandekar et al. 2011). In fact, those more likely to
develop breast cancer are those who are obese and overweight; moreover, increased
BMI values are associated with higher expression of JAK2/STAT3 and NF-jB and
lower expression of SOCS3 (Santilla´n Benı´tez et al. 2012), as shown in Table 2.
Factors such as family history of breast cancer, nulliparity, and breastfeeding
predispose women to develop breast cancer (Youlden et al. 2012); nonetheless, this
study did not find any statistically significant correlation between these factors and
breast cancer (Table 3).
A subsequent study evaluates the effect of bistriazole on NF-jB expression to
substantiate the conclusions of the current, performed study, as this compound could
activate NF-jB through other pathways or not interfere with them. As a result, it is
important to study the proteins that interfere with the activation of NF-kB because
this pathway could be activated through a canonical or a noncanonical pathway,
where different IKKs may participate.
Conclusions
The higher prevalence of breast cancer in Mexico demands innovative alternatives
that contribute to the prevention and treatment of this disease. The expression of
signaling pathways such as JAK2/STAT3 and NF-jB could be used as early
biomarkers of the disease and as new therapeutic targets that function in the
development and progression of breast cancer. Alternative treatments focused on
these signaling pathways, as proposed in this first phase of this study, could achieve
more effective treatments against breast cancer.
Likewise, the risks posed by both being overweight and obese in the development
of breast cancer, for example over-expression of the signaling pathways that alter
the normal development of cells due to these ailments, will contribute to raising
public awareness about the importance of maintaining a healthy lifestyle.
Future studies will further examine the NF-jB pathway to dismiss or substantiate
the effects of bistriazole. We hope to perform studies in animals to evaluate the
signaling pathway of JAK2/STAT3, SOCS3, and NF-jB with this compound.
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